Jaclyn LoPiccolo

Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis <i>In vitro</i> and <i>In vivo</i>

Joell J. Gills, Jaclyn LoPiccolo, Junji Tsurutani et al. · Clinical Cancer Research · 2007 · 326 citations

Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy

Joell J. Gills, Jaclyn LoPiccolo, Phillip A. Dennis · Autophagy · 2008 · 132 citations

Many Paths, Mitophagy, Hiv Protease Inhibitors +22

Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary

Intae Moon, Jaclyn LoPiccolo, Sylvan C. Baca et al. · Nature Medicine · 2023 · 98 citations · Full text

Treatment Response Prediction, Engineering, Tumor Heterogeneity +14

A Central Role for Foxp3+ Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis

Courtney A. Granville, Regan M. Memmott, Andria Balogh et al. · PLoS ONE · 2009 · 78 citations · Full text

Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells

Shigeru Kawabata, Joell J. Gills, J R Mercado-Matos et al. · Cell Death and Disease · 2012 · 72 citations · Full text